Table 4 |
|||
|
A comparison between the LR+RT- and LR-RT- subgroups |
|||
|
Factor |
LR+RT- |
LR-RT- |
P value |
|
|
|||
|
ER status, number |
|||
|
Negative |
8 |
6 |
|
|
Positive |
14 |
27 |
0.21a |
|
Median age, years |
|||
|
All |
53 |
61 |
0.02b |
|
ER- subgroup |
59.5 |
54 |
0.90 |
|
ER+ subgroup |
50.5 |
62 |
0.02 |
|
Histological grade, number |
|||
|
1 |
4 |
13 |
|
|
2 |
10 |
9 |
|
|
3 |
5 |
8 |
0.19a |
|
Median tumor size, millimeters |
15 |
14 |
0.67b |
|
|
|||
|
Only cases from inclusion 1 are included. aFisher exact test. bWilcoxon rank sum test. ER, = estrogen receptor; LR-RT- = no local recurrence, no radiotherapy given; LR+RT- = local recurrence developed, no radiotherapy given. |
|||
|
Niméus-Malmström et al. Breast Cancer Research 2008 10:R34 doi:10.1186/bcr1997 |
|||